News & Events

NEWS
Press-Release
October 1, 2018
InSysBio Announces Continuation of Collaboration with MedImmune for Quantitative Systems Pharmacology Modeling in Systemic Lupus Erythematosus
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced today an extension of a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, for QSP modeling in systemic lupus erythematosus (SLE). The goal is to support the clinical development of anifrolumab, an investigational monoclonal antibody against the type I interferon receptor, by modeling the contributions of key cell types involved in the pathophysiology of lupus that are associated with the type I interferon dysregulation commonly seen with the disease.
LEARN MORE
NEWS
Software
September 26, 2018
InSysBio launches Immune Response Template online
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Immune Response Template (IRT) online. IRT is a QSP platform of human immune system and a tool for development of custom QSP models related to immune response.
LEARN MORE
NEWS
Press-Release
September 11, 2018
InSysBio launches Alzheimer’s Disease Modeling Consortium
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Alzheimer’s Disease (AD) Modeling Consortium. The aim of the consortium is the support of drug development in AD by consolidation of efforts of teams from various pharmaceutical companies in framework of development and application of AD QSP platform.
LEARN MORE
NEWS
Press-Release
August 15, 2018
InSysBio creates a legal entity in UK
InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the registration of legal entity in UK. InSysBio UK (INSYSBIO UK LIMITED) is located in Edinburgh.
LEARN MORE
events
Conference
July 17, 2018
InSysBio to present at AAIC 2018
InSysBio announces their participation at Alzheimer’s Association International Conference (AAIC) 2018 being held July 22-26 in Chicago, IL. InSysBio welcomes visitors at the booth #630.
LEARN MORE
NEWS
Press-Release
June 13, 2018
InSysBio Announces Collaboration on Quantitative System Pharmacology Modeling of Chronic Obstructive Pulmonary Disease
InSysBio LLC (www.insysbio.com), a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a collaboration with GSK, one of the world's leading research-based pharmaceutical and healthcare companies, for development of QSP platform of Chronic Obstructive Pulmonary Disease (COPD).
LEARN MORE
January 2023
MoTuWeThFrSaSu
      
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
1. 16 Jan 2023 15:18 InSysBio team to publish the new article “Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study” The new article by Dmitry Shchelokov and Oleg Demin Jr was published in mAbs journal at the end of December 2022
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
     
Upcoming Events
Tags